(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ENDOFORM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ENDOFORM

ST13

US500000079325081

Class

5

Filing

79325081

Registration

6909104

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

05/31/2025

Trademark type

Word

Nice classes

5

Filing date

07/14/2021

Registration date

11/29/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/29/2022

Last transaction

05/31/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

NZ

Examiner

ROBERTSON, DEIRDRE

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

AROA BIOSURGERY LIMITED

Representatives

Bradley P. Heisler c/o Potter IP Limited

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticalmedical and veterinary preparations for use in wound care and soft tissue reconstruction; sanitary preparations for medical purposes; medical plasters; preparations containing collagen for medical purposesmedicalsurgicalwound dressings; surgical mesh comprised primarily of living tissue; medical dressings; surgical dressings; medical and surgical dressings in powdered form; dressings for wounds; materials for dressing woundsmedicalsurgicalwound dressings; antiseptic preparations for wound care; bandages for skin wounds; dressings to cover and protect wounds; pharmaceutical preparations for wounds; medical and surgical dressings comprised primarily of an extracellular matrix incorporating animal tissue for use in plastic reconstructive surgery; plasters for medical purposes; medicalsurgical and wound dressings comprised primarily of an extracellular matrix incorporating animal tissue for use in repairreinforcement or buttressing of soft tissue

Publications

History of USPTO decisions and trademark events.

31 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/30/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/12/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/21/2023

FIMP

FINAL DISPOSITION PROCESSED

03/21/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/28/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/07/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/29/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

11/29/2022

GPNX

NOTIFICATION PROCESSED BY IB

09/27/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/13/2022

PUBO

PUBLISHED FOR OPPOSITION

09/13/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/07/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/07/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/24/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/09/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/08/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/08/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/08/2022

RFNT

REFUSAL PROCESSED BY IB

04/18/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/29/2022

RFRR

REFUSAL PROCESSED BY MPU

03/29/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/29/2022

CNRT

NON-FINAL ACTION WRITTEN

03/28/2022

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

03/28/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/25/2022

CNRT

NON-FINAL ACTION WRITTEN

02/24/2022

DOCK

ASSIGNED TO EXAMINER

02/22/2022

MAFR

APPLICATION FILING RECEIPT MAILED

11/20/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/16/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

11/15/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/11/2021

Continuous trademark protection

Get notified about every new filing that threatens ENDOFORM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.